Mülheim an der Ruhr, Germany 1/7/13; Llantrisant, UK 1/20/13— Schauenburg International Group, a technology business, has acquired a majority stake in Markes International for an undisclosed amount. Markes management are co-owners. Markes is a provider of thermal desorption technology, and its ALMSCO division supplies TOF-MS systems. All employees and management will remain with the company. […]

Carlsbad, CA 1/22/12—Life Technologies has acquired Netherlands-based BAC, a provider of protein purification products, including affinity ligands, for biopharmaceutical research and manufacturing. Financial terms were not announced. “Our acquisition of BAC BV positions Life Technologies as a leading provider of end-to-end solutions that are widely utilized in the bioprocess workflow,” said Tony Hunt, head of […]

Sanford, ME 1/3/13—Maine Manufacturing has acquired a number of life science product lines from GE Healthcare. These product lines consist of microbiological monitors, liquid growth media, the ZapCap brand bottle-top filtration units and the Centrex brand centrifugal filers. “The addition of these products fits very nicely with our recently announced acquisition of the filter and […]

Radnor, PA 1/3/13—VWR International has appointed Manuel Brocke-Benz president and CEO, effective immediately. He had been serving as interim CEO following the resignation of former CEO John Ballbach last year (see IBO 7/31/12). He was appointed to the Board in September 2012. Mr. Brocke-Benz previously served as senior vice president and managing director of Europe. […]

San Diego, CA 1/14/13—Accelrys has acquired Vialis for $5 million and the potential for additional incentive consideration of up to $5 million based on three-year growth objectives. Based in Switzerland, Vialis provides software systems integration and business process consultancy services to the pharmaceutical, biotechnology, chemicals and agro-science industries. Accelrys and Vialis are long-time partners. “With […]

San Diego, CA 1/7/13; Waltham, MA and Redwood City, CA 1/9/13—Illumina has agreed to acquire Verinata Health, a provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for $350 million and up to an additional $100 in milestone payments through 2015. Verinata Health’s verifi prenatal test utilizes next-generation sequencing to analyze cell-free […]

New York, NY 1/8/12—At the JPMorgan Global Healthcare Conference, Illumina announced the acquisition of Moleculo, a provider of technology enabling next-generation sequencing reads in excess of 10,000 bases. Illumina stated that it plans to commercialize the technology in the second quarter for phased genomes (indicating which parent an allele comes from) and for cancer research, […]

Santa Clara, CA 1/8/13—Affymetrix has announced preliminary 2012 revenues and a restructuring plan to improve profitability. The company estimates fourth-quarter revenues totaled $84 million, including $18 million in eBioscience sales. Year over year, revenue increased 1% excluding eBioscience, and eBioscience revenue grew 5%. Year-end revenues are estimated to be $295 million. The restructuring, which includes […]

Jena, Germany and Osaka, Japan 12/3/12—Analytik Jena has purchased a 21.1% stake in Japanese firm Techno X. Analytik Jena has sold Techno X’s X-ray fluorescence spectroscopy (XRF) instruments in Japan since October 2011 (see IBO 12/31/11). “We are also pleased that the sales partnership in which we are linking our partner’s technological expertise in X-ray […]